CompletedPhase 1NCT00405860

CellCept in p-ANCA Vasculitis

Studying Vasculitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mayo Clinic
Principal Investigator
Fernando C. Fervenza, M.D., Ph.D.
Mayo Clinic
Intervention
CellCept (mycophenolate mofetil)(drug)
Enrollment
18 enrolled
Eligibility
18 years · All sexes
Timeline
20022008

Study locations (1)

Collaborators

Roche Pharma AG

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00405860 on ClinicalTrials.gov

Other trials for Vasculitis

Additional recruiting or active studies for the same condition.

See all trials for Vasculitis

← Back to all trials